Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes

Molecular and Cellular Biochemistry

Volumn 409, Issue 1-2, 2015, Pages 243-253

  Lewko, Barbara ^a,b   Waszkiewicz, Anna ^a   Maryn, Anna ^a   Gołos, Magdalena ^a   Latawiec, Elżbieta ^a   Daca, Agnieszka ^a   Witkowski, Jacek M ^a   Angielski, Stefan ^b   Stępiński, Jan ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Angiotensin II; cGMP; Dexamethasone; Mechanical stress; Motility; Podocytes

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; CYCLIC GMP; DEXAMETHASONE; F ACTIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; ANTIINFLAMMATORY AGENT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DRUG MECHANISM; GLOMERULUS; MECHANICAL STRESS; MOUSE; NONHUMAN; PODOCYTE; RAT; RENOVASCULAR HYPERTENSION; WOUND HEALING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; DRUG EFFECTS; FLOW CYTOMETRY; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS; ATRIAL NATRIURETIC FACTOR; CELL MOVEMENT; CELLS, CULTURED; CYCLIC GMP; DEXAMETHASONE; FLOW CYTOMETRY; MICE; NITRIC OXIDE; PODOCYTES; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ATRIAL NATRIURETIC FACTOR; S-NITROSO-N-ACETYLPENICILLAMINE; STRESS, PHYSIOLOGICAL; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84942986708     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2528-6     Document Type: Article

References (53)

1. Schoneveld OJ, Gaemers IC, Lamers WH (2004) Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 1680:114–128. doi:10.1016/j.bbaexp.2004.09.004
2. Stahn C, Buttgereit F (2008) Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 4:525–533. doi:10.1038/ncprheum0898
3. Ding WY, Saleem MA (2012) Current concepts of the podocyte in nephrotic syndrome. Kidney Res Clin Pract 31:87–93. doi:10.1016/j.krcp.2012.04.323
4. Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW (2006) Direct effects of dexamethasone on human podocytes. Kidney Int 70:1038–1045
5. Ma H, Togawa A, Soda K, Zhang J, Lee S, Ma M, Yu Z, Ardito T, Czyzyk J, Diggs L, Joly D, Hatakeyama S, Kawahara E, Holzman L, Guan JL, Ishibe S (2010) Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J Am Soc Nephrol 21:1145–1156. doi:10.1681/asn.2009090991
6. Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE (2005) Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 68:2473–2483. doi:10.1111/j.1523-1755.2005.00723.x
7. Endlich N, Endlich K (2012) The challenge and response of podocytes to glomerular hypertension. Semin Nephrol 32:327–341. doi:10.1016/j.semnephrol.2012.06.004
8. Lewko B, Endlich N, Kriz W, Stepinski J, Endlich K (2004) C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress. Kidney Int 66:1001–1008
9. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, Pichler R, Griffin S, Couser WG, Shankland SJ (2004) Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 65:30–39
10. Pavenstadt H, Kriz W, Kretzler M (2003) Cell biology of the glomerular podocyte. Physiol Rev 83:253–307
11. Saleem MA, Zavadil J, Bailly M, McGee K, Witherden IR, Pavenstadt H, Hsu H, Sanday J, Satchell SC, Lennon R, Ni L, Bottinger EP, Mundel P, Mathieson PW (2008) The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells. Am J Physiol Renal Physiol 295:F959–F970. doi:10.1152/ajprenal.00559.2007
12. Piwkowska A, Rogacka D, Jankowski M, Kocbuch K, Angielski S (2012) Hydrogen peroxide induces dimerization of protein kinase G type Ialpha subunits and increases albumin permeability in cultured rat podocytes. J Cell Physiol 227:1004–1016. doi:10.1002/jcp.22810
13. Velez JC, Bland AM, Arthur JM, Raymond JR, Janech MG (2007) Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 293:F398–F407
14. Lewko B, Golos M, Latawiec E, Angielski S, Stepinski J (2006) Regulation of cGMP synthesis in cultured podocytes by vasoactive hormones. J Physiol Pharmacol 57:599–610
15. Pavenstadt H (2000) Roles of the podocyte in glomerular function. Am J Physiol Renal Physiol 278(2):F173–F179
16. Stepinski J, Wendt U, Lewko B, Angielski S (2000) Co-operation between particulate and soluble guanylyl cyclase systems in the rat renal glomeruli. J Physiol Pharmacol 51:497–511
17. Golos M, Lewko B, Bryl E, Witkowski JM, Dubaniewicz A, Olszewska A, Latawiec E, Angielski S, Stepinski J (2002) Effect of angiotensin II on ANP-dependent guanylyl cyclase activity in cultured mouse and rat podocytes. Kidney Blood Press Res 25:296–302
18. Lewko B, Wendt U, Szczepanska-Konkel M, Stepinski J, Drewnowska K, Angielski S (1997) Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli. Kidney Int 52:654–659
19. Kobayashi N, Reiser J, Schwarz K, Sakai T, Kriz W, Mundel P (2001) Process formation of podocytes: morphogenetic activity of microtubules and regulation by protein serine/threonine phosphatase PP2A. Histochem Cell Biol 115:255–266
20. Guess A, Agrawal S, Wei CC, Ransom RF, Benndorf R, Smoyer WE (2010) Dose- and time-dependent glucocorticoid receptor signaling in podocytes. Am J Physiol Renal Physiol 299(4):F845–F853
21. Endlich N, Kress KR, Reiser J, Uttenweiler D, Kriz W, Mundel P, Endlich K (2001) Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 12:413–422
22. Steiner AL, Pagliara AS, Chase LR, Kipnis DM (1972) Radioimmunoassay for cyclic nucleotides. II. Adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in mammalian tissues and body fluids. J Biol Chem 247:1114–1120
23. Lewko B, Wendt U, Stepinski J, Angielski S (1993) Dexamethasone sensitizes soluble guanylate cyclase in the rat renal glomeruli. Biochem Biophys Res Commun 197:826–832. doi:10.1006/bbrc.1993.2553
24. Endlich N, Schordan E, Cohen CD, Kretzler M, Lewko B, Welsch T, Kriz W, Otey CA, Endlich K, European Renal c DNABC (2009) Palladin is a dynamic actin-associated protein in podocytes. Kidney Int 75:214–226
25. Scarborough RM, McEnroe GA, Arfsten A, Kang LL, Schwartz K, Lewicki JA (1988) d-Amino acid-substituted atrial natriuretic peptide analogs reveal novel receptor recognition requirements. J Biol Chem 263:16818–16822
26. Sato A, Suzuki H, Murakami M, Nakazato Y, Iwaita Y, Saruta T (1994) Glucocorticoid increases angiotensin II type 1 receptor and its gene expression. Hypertension 23:25–30
27. Ullian ME, Walsh LG, Morinelli TA (1996) Potentiation of angiotensin II action by corticosteroids in vascular tissue. Cardiovasc Res 32:266–273
28. Bogdarina IG, King PJ, Clark AJ (2009) Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids. J Mol Endocrinol 43:73–80. doi:10.1677/jme-09-0036
29. Chansel D, Llorens-Cortes C, Vandermeersch S, Pham P, Ardaillou R (1996) Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells. Hypertension 27:867–874
30. Endlich N, Sunohara M, Nietfeld W, Wolski EW, Schiwek D, Kranzlin B, Gretz N, Kriz W, Eickhoff H, Endlich K (2002) Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J 16:1850–1852
31. Guo D, Tan YC, Wang D, Madhusoodanan KS, Zheng Y, Maack T, Zhang JJ, Huang XY (2007) A Rac-cGMP signaling pathway. Cell 128:341–355. doi:10.1016/j.cell.2006.11.048
32. Mayanagi T, Morita T, Hayashi K, Fukumoto K, Sobue K (2008) Glucocorticoid receptor-mediated expression of caldesmon regulates cell migration via the reorganization of the actin cytoskeleton. J Biol Chem 283:31183–31196. doi:10.1074/jbc.M801606200
33. Greenbaum LA, Benndorf R, Smoyer WE (2012) Childhood nephrotic syndrome–current and future therapies. Nat Rev Nephrol 8:445–458. doi:10.1038/nrneph.2012.115
34. Khurana S, Bruggeman LA, Kao HY (2012) Nuclear hormone receptors in podocytes. Cell Biosci 2:33. doi:10.1186/2045-3701-2-33
35. Mathieson PW (2012) The podocyte as a target for therapies–new and old. Nat Rev Nephrol 8:52–56. doi:10.1038/nrneph.2011.171
36. Castro LR, Schittl J, Fischmeister R (2010) Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes. Circ Res 107:1232–1240. doi:10.1161/circresaha.110.226712
37. Yan K, Kudo A, Hirano H, Watanabe T, Tasaka T, Kataoka S, Nakajima N, Nishibori Y, Shibata T, Kohsaka T, Higashihara E, Tanaka H, Watanabe H, Nagasawa T, Awa S (1999) Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int 56:65–73. doi:10.1046/j.1523-1755.1999.00503.x
38. Wada T, Pippin JW, Nangaku M, Shankland SJ (2008) Dexamethasone’s prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation. Nephron Expl Nephrol 109:e8–19
39. Beck IM, Vanden Berghe W, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher K (2009) Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev 30:830–882. doi:10.1210/er.2009-0013
40. Yoshioka T, Kawamura T, Meyrick BO, Beckman JK, Hoover RL, Yoshida H, Ichikawa I (1994) Induction of manganese superoxide dismutase by glucocorticoids in glomerular cells. Kidney Int 45:211–219
41. Graf K, Schaper C, Grafe M, Fleck E, Kunkel G (1998) Glucocorticoids and protein kinase C regulate neutral endopeptidase 24.11 in human vascular smooth muscle cells. Basic Res Cardiol 93:11–17
42. Ronco P, Debiec H (2007) Podocyte antigens and glomerular disease. Nephron Exp Nephrol 107:e41–e46
43. Liu C, Chen Y, Kang Y, Ni Z, Xiu H, Guan J, Liu K (2011) Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure. J Pharmacol Exp Ther 339:203–209. doi:10.1124/jpet.111.184796
44. Ardaillou N, Blaise V, Placier S, Amestoy F, Ardaillou R (1996) Dexamethasone upregulates ANP C-receptor protein in human mesangial cells without affecting mRNA. Am J Physiol 270:F440–F446
45. Kanda K, Ogawa K, Miyamoto N, Hatano T, Seo H, Matsui N (1989) Potentiation of atrial natriuretic peptide-stimulated cyclic guanosine monophosphate formation by glucocorticoids in cultured rat renal cells. Br J Pharmacol 96:795–800
46. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Takeda T (1990) Glucocorticoids and atrial natriuretic factor receptors on vascular smooth muscle. Hypertension 16:581–586
47. Sager G (2004) Cyclic GMP transporters. Neurochem Int 4:865–873. doi:10.1016/j.neuint.2004.03.017
48. Bahn A, Hauss A, Appenroth D, Ebbinghaus D, Hagos Y, Steinmetzer P, Burckhardt G, Fleck C (2003) RT-PCR-based evidence for the in vivo stimulation of renal tubularp-aminohippurate (PAH) transport by triiodothyronine (T3) or dexamethasone (DEXA) in kidney tissue of immature and adult rats. Exp Toxicol Pathol 54:367–373. doi:10.1078/0940-2993-00272
49. Brown C, Pan X, Hassid A (1999) Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. Circ Res 84:655–667
50. Reiser J, Oh J, Shirato I, Asanuma K, Hug A, Mundel TM, Honey K, Ishidoh K, Kominami E, Kreidberg JA, Tomino Y, Mundel P (2004) Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and α3 integrin. J Biol Chem 279:34827–34832. doi:10.1074/jbc.M401973200
51. Endlich N, Endlich K (2006) Stretch, tension and adhesion—adaptive mechanisms of the actin cytoskeleton in podocytes. Eur J Cell Biol 85:229–234
52. Tian D, Jacobo SM, Billing D, Rozkalne A, Gage SD, Anagnostou T, Pavenstadt H, Hsu HH, Schlondorff J, Ramos A, Greka A (2010) Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci Signal 3:ra77. doi:10.1126/scisignal.2001200
53. Wang L, Ellis MJ, Gomez JA, Eisner W, Fennell W, Howell DN, Ruiz P, Fields TA, Spurney RF (2012) Mechanisms of the proteinuria induced by Rho GTPases. Kidney Int 81:1075–1085. doi:10.1038/ki.2011.472